Pharmacokinetics, disposition and metabolism of 546C88 (L-N^G-methylarginine hydrochloride) in rat and dog

References

• ARCHER, S. L. and HAMPL, S. L., 1992, NG-monomethyl-L-arginine causes nitric oxide synthesis in isolated arterial rings: trouble in paradise. Biochemical and Biophysical Research Communications, 188, 590–596.
   Google Scholar
• BLACHIER, F., DARCY-VRILLON, B., SENER, A., DUE, P. H. and MALAISSE, W. J., 1991, Arginine metabolism in rat enterocytes. Biochimica et Biophysica Acta, 1092, 304–310.
   Google Scholar
• COOPER, J. D. H., SHEARSBY, N. and FOOK SHEUNG, C. T. C., 1997, Use of the ASTED system to determine L-NG-monomethylargirine (546C88) in human plasma by pre-column o-phthal-aldehyde derivatisation and high pressure liquid chromatography Journal of Chromatography B, 696, 117–122.
   Google Scholar
• COOPER, J. D. H., TURNELL, D. C. and GREEN, B., 1988, Automated sequential trace enrichment of dialysates and robotics. A technique for the preparation of biological samples prior to high-perform ance liquid chrom atography. journal of Chromatography, 456, 53–69.
   Google Scholar
• FELDMAN, P. L., GRIFFITH, O. W., HONG, H. and STUEHR, D. J., 1993, Irreversible inactivation of macrophage and brain nitric oxide synthase by L-NG-methylarginine requires NADPH-dependent hydroxylation.Yourna/ of Medicinal Chemistry, 36, 491–496.
   PubMed Web of Science ®Google Scholar
• HECKER, H., MITCHELL, J. A., HARRIS, H. H., KATSURA, M., THEIMERMANN, C. and VANE, J. R., 1990, Endothelial cells metabolise NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine. Biochemical and Biophysical Research Communications, 167, 1037–1043.
   PubMed Web of Science ®Google Scholar
• HOPPEL, C. L., Cox, R. A. and NOVAK, R. F., 1980, N6-trimethyl-lysine metabolism. Biochemical Journal, 188, 509–519.
   Google Scholar
• KIMOTO M., TSUJI, H., OGAWA, T. and SASAOKA, K., 1993, Detection of N', NG-dimentylarginire dim ethylaminohylrolase in the nitric oxide-generating system s of rats using monoclonalantibody. Archives of Biochemistry and Biophysics, 300, 657–662.
   Google Scholar
• LEHNINGER, A. L., 1975, Biochemistry (New York: Worth), pp. 574–575.
   Google Scholar
• MACALLISTER, R. J., FICICLING, S. A., WHITLEY, G. S. J. and VALLANCE, P., 1994, Metabolism of methylargininesby human vasculature; implications for the regulation of nitric oxide synthesis. British Journal of Pharmacology, 112, 43–48.
   Google Scholar
• MARLETTA, M. A., 1989, Nitric oxide: biosynthesis and biological significance. Trends in Biochemical Science, 14, 488–492.
   PubMed Web of Science ®Google Scholar
• McCALL, T. B., FEELISCH M., PALMER, R. M. J. and MONCADA, S., 1991, Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthease in phagocytic cells. British Journal of Pharmacology, 102, 234–238.
   Google Scholar
• MCDERMOTT, J. R., 1976, Studies on the catabolism of NGmethylarginine,NG, N'G-dimentylarginire and NG, NG-dimethylarginire in the rabbit. Biochemical Journal, 154, 179–184.
   PubMed Web of Science ®Google Scholar
• MONCADA S., PALMER, R. M. J. and HIGGS, E. A.,1991, Nitric oxide: physiology,pathophysiology, and pharmacology. Pharmacological Reviews, 43, 109–142.
   Google Scholar
• OGAWA, T., KLMOTO, M., WATANABE, H. and SASAOKA, K., 1987, Metabolism of N', /VG- and NG, N'' - dim ethyl-L-arginine in rats. Archives of Biochemistry and Biophysics, 252, 526–537.
   PubMed Web of Science ®Google Scholar
• OGAWA, T., KLMOTO, M. and SASAOKA, K., 1989, Purification and properties of a new enzyme, NG, NG - dim ethylarginire dim ethylam inohylrolase, from rat kidney.Journal of Biological Chemistry, 264, 10205–10209.
   PubMed Web of Science ®Google Scholar
• OGAWA, T., KLMOTO, M. and SASAOKA, K., 1990, Dimethylarginire:pyruvate am inotransfe raw in rats. Purification, properties, and identity with alanine:glyoxylate aminotransferase 2. Journal of Biological Chemistry, 265, 20938–20945.
   PubMedGoogle Scholar
• OHTA, K., SHIMAZU, K., HOMATSUMOTO, S., ARAKI, N., SHIBATA, M. and FAKuucm, T., 1994, Modification of striatal arginine and citrulline metabolism by nitric oxide synthase inhibitors. NeuroReport, 5, 766–768.
   Google Scholar
• OLKEN, N. M., RUSCHE, L. M., RicHARDs, M. K. and MARLETTA, M. A., 1991, Inactivation of m acrophage nitric oxide synthase activity by NG-methyl-L-arginine. Biochemical and Biophysical Research Communications, 177, 828–833.
   PubMed Web of Science ®Google Scholar
• OLKEN, N. M. and MARLETTA, M. A., 1993, /VG-methyl-L-arginine is an alternate substrate and mechanism-based inhibitor of nitric oxide synthase. FASEB Journal, 7 (abstracts), A1203.
   Google Scholar
• PAIK, W. K., ABOU -GHARBIA M., SWERN, D., LOTLIKAR, P. and KIM, S., 1983, Metabolism of NG- monomethyl-L-arginine. Canadian Journal of Biochemistry and Cell Biology, 61, 850–855.
   Google Scholar
• PAIK, W. K., KIM, S., HUTHCHINS, M. G. and SWERN, D., 1981, Metabolism of NG-monomethyl-L-arginine: formation of NG-methylagmatineby Escherkhia coli preparation. Canadian Journal of Biochemistry, 59, 131–136.
   Google Scholar
• REES, D. D ., PALMER, R. M. J., ScHuLz, R., HODSON, H. F. and MONCADA, S., 1990, Characterisation of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. British Journal of Pharmacology, 101, 746–752.
   Google Scholar
• ROBERTSON, C. A., GREEN, B. G., NIEDZWIECKI, L., HARRISON, R. K. and FRANT, S. K., 1993, Effect of nitric oxide synthase substrate analogue inhibitors on rat liver arginase. Biochemical and Biophysical Research Communications, 197, 523–528.
   Google Scholar
• SCHUSTE R., 1980, Determination of free amino acids by high performance liquid chromatography. Analytical Chemistry, 52, 617–620.
   Google Scholar
• UNEO, S., SANO, A., KOTANI, K., KONDOH, K. and KAIMOTO, Y., 1992, Distribution of free methylargininesin rat tissues and in the bovine brain. journal of Neurochemistry, 59, 2012–2016.
   Google Scholar